Unpaid caregivers have always played an important role in healthcare, but thanks to rapidly aging populations and shrinking physician resources, they’re becoming critical. And that means they need to be critical for pharma, too.
In fact, drugmakers should treat the more than 43.5 million U.S. caregivers as an actual demographic group, as they do mothers or baby boomers, Syneos Health says in its trend prediction report for 2020.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,